PUBLIC CONTRACT · 2024
06/01663.11/2024 - Aquisição de Mepolizumab 100 mg/1 ml Sol inj Caneta 1 ml SC (2021/012)
- Contract value
- €198,936.84
- Signed on
- 18 April 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10674714PUBLISHED SUBJECT
06/01663.11/2024 - Aquisição de Mepolizumab 100 mg/1 ml Sol inj Caneta 1 ml SC (2021/012)
Parties involved
- Place of performance
- Portugal, Aveiro, Santa Maria da Feira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GLAXOSMITHKLINE - PRODUTOS FARMACÊUTICOS, LDA · Tax ID 500139962
Values and timeline
- Contract price
- €198,936.84
- Procedure base price
- €198,936.84
- Total effective price
- Not reported on Portal BASE
- Publication date
- 18 April 2024
- Award date
- 15 April 2024
- Signing date
- 18 April 2024
- Performance period
- 269 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/12 - Medicamentos do aparelho respiratório
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6989529
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.